Ixekizumab , approved for plaque psoriasis , is an antibody to IL - 17 itself ( rather than the receptor ) .
Approved anti-IL17 ( R ) drugs include : Brodalumab ( Siliq ) , an antibody to the receptor , approved for psoriasis .
Ixekizumab , approved for plaque psoriasis , is an antibody to anti-IL17     itself ( rather than the receptor ) .
Approved anti-IL17 ( R ) drugs include : Brodalumab ( Siliq ) , an antibody to the receptor , approved for psoriasis .